Highlights

  • Elevate Uranium (ASX:EL8) shares traded at AUD 0.27, down 5.26% at the time of writing on 2 September 2026.
  • The company is advancing uranium projects across Namibia and Australia, supported by its proprietary U-pgrade™ beneficiation process.
  • Elevate increased its ownership position in the Marenica Uranium Project following transactions announced in July and August 2026.
  • Investors are monitoring pilot plant outcomes, project development milestones and uranium market conditions.

The Australian Equity market traded lower during the session, with the S&P/ASX 200 (ASX:XJO) trading at 8,969.00 points, down 1.08% today, while the S&P/ASX 300 (ASX:XKO) was trading at 8,898.40 points, down 1.09% today. Within the energy segment, the S&P/ASX 200 Energy (ASX:XEJ) was trading at 11,196.80 points, up 0.46% today.

Elevate Uranium Limited (ASX:EL8) recorded a share price of AUD 0.27, down 5.26%, at the time of writing on 2 September 2026. The daily movement reflects market activity around the company’s shares, although short-term price changes alone do not necessarily represent changes in project value, resource potential or long-term Business fundamentals.

Uranium Strategy

Elevate Uranium (ASX:EL8) is a uranium exploration and development company focused on advancing uranium resources across Namibia and Australia. The company’s strategy centres on developing large-scale uranium Assets while applying its proprietary U-pgrade™ beneficiation process.

The company’s Namibian portfolio includes the Marenica Uranium Project and the Koppies Uranium Project, both located in the Erongo uranium province. In Australia, Elevate holds interests across several uranium projects, including Angela, Napperby, Thatcher Soak, Minerva, Bigrlyi, Malawiri, Walbiri and Areva joint ventures.

Elevate has highlighted a total Mineral Resource portfolio of 181 million pounds of U3O8 across its projects in Namibia and Australia.

The company’s U-pgrade™ technology is designed to improve uranium concentration through beneficiation before conventional processing. Elevate has stated that test work has demonstrated the potential to significantly reduce waste material and improve processing efficiency compared with traditional approaches.

Marenica Expansion

A key development during 2026 has been Elevate’s increased ownership position in the Marenica Uranium Project.

In August 2026, Elevate provided an update on the Acquisition process for additional ownership in Marenica Minerals, the company holding the Marenica Uranium Project in Namibia. Elevate advised that it had completed the transaction to acquire an additional 10% interest and had extended the closing date for the remaining 5% acquisition to 30 September 2026. The company stated that it currently owns 85% of Marenica, with the completion of the additional transaction expected to increase ownership to 90%.

The increased ownership position provides Elevate with greater exposure to the Marenica asset and increased control over future development decisions.

The Marenica Uranium Project remains a significant component of the company’s Namibian portfolio. Elevate has previously reported that the project contains a JORC 2012 Mineral Resource of 47.5 million pounds of U3O8 attributable to Elevate’s share.

The company has also continued work on advancing its U-pgrade™ beneficiation process, with Marenica ore samples forming a key part of pilot plant activities.

Technology Progress

In August 2026, Elevate Uranium reported results from its U-pgrade™ pilot plant program, providing an operational update on progress across the five-stage beneficiation circuit.

The company reported that several challenges identified during pilot plant operations had been addressed, with optimisation continuing across the circuit. Elevate highlighted progress in removing acid-consuming minerals through the calcite flotation stage, which it said could support simpler leaching requirements and influence future processing plant design considerations.

The pilot plant program is intended to generate technical data to support further development studies for the Marenica project.

For uranium developers, processing technology can play an important role in determining project economics. The ability to improve recovery rates, reduce processing requirements or lower operating complexity can influence development pathways.

However, moving from laboratory and pilot-scale results to commercial application involves additional engineering, technical validation and economic assessment.

Market Factors

Uranium companies are influenced by a range of factors including Commodity prices, nuclear energy demand, project advancement, funding conditions and investor sentiment towards resources stocks.

Elevate Uranium’s daily decline of 5.26% may reflect broader market activity, uranium sector sentiment or individual investor positioning. However, a single Trading session does not necessarily indicate a change in the company’s operational outlook or asset quality.

Investors generally assess uranium developers by examining resource scale, project location, development timelines, processing strategies and Capital requirements.

The uranium sector continues to receive attention due to discussions around nuclear power generation, energy security and long-term electricity demand. At the same time, developers must navigate technical, regulatory and financing challenges before reaching commercial production.

For Elevate, progress across Marenica, Koppies and the U-pgrade™ technology program remains central to market evaluation.

Investor Focus

Investor attention on Elevate Uranium (ASX:EL8) remains centred on how the company advances its uranium portfolio and converts its resource base into potential future development opportunities.

The increased ownership position at Marenica provides greater exposure to one of the company’s key Namibian assets, while ongoing pilot plant work is aimed at improving understanding of the U-pgrade™ process.

The company’s ability to demonstrate technical success, complete further development studies and manage future funding requirements will likely remain important areas monitored by investors.

Beyond individual project milestones, broader uranium market conditions and Demand expectations will continue to influence sentiment towards uranium exploration and development companies.

Final Takeaway

Elevate Uranium (ASX:EL8) continues to progress its uranium development strategy through ownership consolidation, technology advancement and resource evaluation. The company’s share price stood at AUD 0.27, down 5.26%, at the time of writing on 2 September 2026.

Recent developments around the Marenica Uranium Project and U-pgrade™ pilot plant program highlight the company’s ongoing focus on advancing its uranium assets.

While daily share price movements reflect market activity, they do not independently determine changes in company fundamentals. Investors continue to monitor Elevate’s project milestones, technology outcomes, ownership developments and the broader uranium market environment.